With the help of Facebook, it is easier than ever before to fundraise globally for the Parkinson’s Foundation.

It can be very difficult for a someone with Parkinson’s disease (PD) to find a home with accessibility features. Most real estate agents don’t have much experience dealing with accessible properties and there are few resources that can simplify the process for disabled home buyers. It takes considerable research and patience to find a property that meets your needs.

First described as a common symptom of Parkinson’s disease (PD) more than 20 years ago, PD-related fatigue remains an under-recognized, clinically significant, disabling symptom that can diminish quality of life (Herlofson et al., 2018; Kluger et al., 2016).

Every three years, the World Parkinson Congress (WPC) provides an international forum where health professionals, care partners and people with Parkinson’s disease (PD) come together to discuss the latest scientific discoveries, medical practices and caregiver initiatives related to Parkinson’s.

Marijuana and Parkinson’s disease (PD) is a hot topic. Watch our newest video, Neuro Talks, where James Beck, PhD, Parkinson’s Foundation Chief Scientific Officer, explains what the PD community should know about marijuana.

Warning: This article contains adult-themed issues and terms.

It might be surprising to learn that 20 to 30 percent of people with Parkinson’s disease (PD) will experience visual hallucinations. While typically not a symptom of PD itself, they can develop as a result to a change in PD medication or as a symptom of an unrelated infection or illness. It is important to know the signs of hallucinations and how to manage them.   

It is estimated that at least 50 percent of people living with Parkinson’s disease (PD) experience depression at some time during the course of their disease. The Parkinson’s Foundation Parkinson’s Outcomes Project found that taken together, mood, depression and anxiety have the greatest impact on health status, even more than the motor impairments commonly associated with the disease.

If you have Parkinson’s disease (PD), or know someone who does, you likely know that PD affects dopamine levels in the brain. But did you know that PD also alters serotonin, norepinephrine and acetylcholine levels? All are chemicals in the brain that affect mood, thinking and behavior.

With medical marijuana legalized in 28 states and Washington, D.C., its therapeutic properties have become buzzworthy. Researchers are currently studying these properties and how they affect different diseases, like Parkinson’s disease (PD). But why?